SCNI vs UPS · P/E 0.2, rev $1.3M vs P/E 15, rev $44.04B
Scinai Immunotherapeutics Ltd (SCNI) versus United Parcel Service Inc (UPS) — a side-by-side from cached financials, not a winner call.
Scinai Immunotherapeutics Ltd (SCNI) is a biotechnology company listed on NASDAQ.
United Parcel Service Inc (UPS) is a integrated freight & logistics company listed on US.
Latest reported SCNI revenue for 2025-12-31 was $1.3M. Net income was -$8.3M. Revenue was up 99.2% from 2024-12-31 to 2025-12-31. SCNI currently screens at market cap $1.8M and trailing P/E 0.2.
Latest reported UPS revenue for 2026-06-30 was $44.04B. Net income was $1.47B. UPS currently screens at market cap $85.76B and trailing P/E 14.8.
SCNI currently screens at market cap $1.8M and trailing P/E 0.2. UPS currently screens at market cap $85.76B and trailing P/E 14.8.
Not investment advice. Open the SCNI and UPS stock pages for the full models.
Not investment advice.